FDA
approval
· 2024-04-15
FDA Approved: CAPECITABINE — Supplemental Application (Cipla USA Inc.)
Summary
The FDA approved Cipla USA Inc.'s supplemental application for Capecitabine, updating regulatory status for this cancer drug. The action likely involves labelin…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for CAPECITABINE (CAPECITABINE)